Literature DB >> 30943551

Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline.

Gianpiero Manes1, Gregorios Paspatis2, Lars Aabakken3, Andrea Anderloni4, Marianna Arvanitakis5, Philippe Ah-Soune6, Marc Barthet7, Dirk Domagk8, Jean-Marc Dumonceau9, Jean-Francois Gigot10, Istvan Hritz11, George Karamanolis12, Andrea Laghi13, Alberto Mariani14, Konstantina Paraskeva15, Jürgen Pohl16, Thierry Ponchon17, Fredrik Swahn18, Rinze W F Ter Steege19, Andrea Tringali20, Antonios Vezakis21, Earl J Williams22, Jeanin E van Hooft23.   

Abstract

ESGE recommends offering stone extraction to all patients with common bile duct stones, symptomatic or not, who are fit enough to tolerate the intervention.Strong recommendation, low quality evidence.ESGE recommends liver function tests and abdominal ultrasonography as the initial diagnostic steps for suspected common bile duct stones. Combining these tests defines the probability of having common bile duct stones.Strong recommendation, moderate quality evidence.ESGE recommends endoscopic ultrasonography or magnetic resonance cholangiopancreatography to diagnose common bile duct stones in patients with persistent clinical suspicion but insufficient evidence of stones on abdominal ultrasonography.Strong recommendation, moderate quality evidence.ESGE recommends the following timing for biliary drainage, preferably endoscopic, in patients with acute cholangitis, classified according to the 2018 revision of the Tokyo Guidelines:- severe, as soon as possible and within 12 hours for patients with septic shock- moderate, within 48 - 72 hours- mild, elective.Strong recommendation, low quality evidence.ESGE recommends endoscopic placement of a temporary biliary plastic stent in patients with irretrievable biliary stones that warrant biliary drainage.Strong recommendation, moderate quality of evidence.ESGE recommends limited sphincterotomy combined with endoscopic papillary large-balloon dilation as the first-line approach to remove difficult common bile duct stones. Strong recommendation, high quality evidence.ESGE recommends the use of cholangioscopy-assisted intraluminal lithotripsy (electrohydraulic or laser) as an effective and safe treatment of difficult bile duct stones.Strong recommendation, moderate quality evidence.ESGE recommends performing a laparoscopic cholecystectomy within 2 weeks from ERCP for patients treated for choledocholithiasis to reduce the conversion rate and the risk of recurrent biliary events. Strong recommendation, moderate quality evidence. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2019        PMID: 30943551     DOI: 10.1055/a-0862-0346

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  73 in total

1.  Controversies in ERCP: frontline Gastroenterology Twitter debate.

Authors:  Muhammad Ishtiaq; Fahd Rana; James Maurice; Matthew T Huggett; Simon M Everett
Journal:  Frontline Gastroenterol       Date:  2020-05-14

2.  Digital single-operator video cholangioscopy in treating refractory biliary stones: a multicenter observational study.

Authors:  Arne Bokemeyer; Christian Gerges; Diana Lang; Dominik Bettenworth; Iyad Kabar; Hartmut Schmidt; Horst Neuhaus; Hansjoerg Ullerich; Frank Lenze; Torsten Beyna
Journal:  Surg Endosc       Date:  2019-07-15       Impact factor: 4.584

3.  UEG Week 2020 Oral Presentations.

Authors: 
Journal:  United European Gastroenterol J       Date:  2020-10       Impact factor: 4.623

4.  Primary duct closure versus T-tube drainage after laparoscopic common bile duct exploration: a meta-analysis.

Authors:  Taifeng Zhu; Haoming Lin; Jian Sun; Chao Liu; Rui Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2021-12-15       Impact factor: 3.066

5.  Endoscopic intraductal lithotripsy of biliary stones using thulium laser: preliminary results of a single-center experience.

Authors:  Lorenzo Dioscoridi; Edoardo Forti; Francesco Pugliese; Marcello Cintolo; Giulia Bonato; Francesca Aprile; Alessio Renga; Massimiliano Mutignani
Journal:  Lasers Med Sci       Date:  2021-07-26       Impact factor: 3.161

6.  ERCP within 6 or 12 h for acute cholangitis: a propensity score-matched analysis.

Authors:  Aymeric Becq; Madhuri Chandnani; Anthony Bartley; Alexandre Nuzzo; Mohammad Bilal; Shishira Bharadwaj; Jonah Cohen; Moamen Gabr; Tyler M Berzin; Douglas K Pleskow; Mandeep S Sawhney
Journal:  Surg Endosc       Date:  2021-05-11       Impact factor: 4.584

Review 7.  Comparison of intraoperative endoscopic retrograde cholangiopancreatography and laparoscopic common bile duct exploration combined with laparoscopic cholecystectomy for treating gallstones and common bile duct stones: a systematic review and meta-analysis.

Authors:  Caining Lei; Tingting Lu; Wenwen Yang; Man Yang; Hongwei Tian; Shaoming Song; Shiyi Gong; Jia Yang; Wenjie Jiang; Kehu Yang; Tiankang Guo
Journal:  Surg Endosc       Date:  2021-07-26       Impact factor: 4.584

8.  Laparoscopic transcystic common bile duct exploration as treatment for choledocholithiasis after Roux-en-Y gastric bypass.

Authors:  Ignacio Fuente; Axel Beskow; Fernando Wright; Pedro Uad; Martín de Santibañes; Martin Palavecino; Rodrigo Sanchez-Claria; Juan Pekolj; Oscar Mazza
Journal:  Surg Endosc       Date:  2021-01-04       Impact factor: 4.584

9.  Do endosonographers agree on the presence of bile duct sludge and the subsequent need for intervention?

Authors:  Rutger Quispel; Hannah M Schutz; Nora D Hallensleben; Abha Bhalla; Robin Timmer; Jeanin E van Hooft; Niels G Venneman; Nicole S Erler; Bart J Veldt; Lydi M J W van Driel; Marco J Bruno
Journal:  Endosc Int Open       Date:  2021-05-27

10.  Outcomes of Laparoscopic Common Bile Duct Exploration by Chopstick Technique in Choledocholithiasis.

Authors:  Tharathorn Suwatthanarak; Thawatchai Akaraviputh; Chainarong Phalanusitthepha; Vitoon Chinswangwatanakul; Asada Methasate; Jirawat Swangsri; Atthaphorn Trakarnsanga; Thammawat Parakonthun; Voraboot Taweerutchana; Nicha Srisuworanan
Journal:  JSLS       Date:  2021 Apr-Jun       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.